Combining Clinical and Molecular Data to Predict the Benefits of Carmustine Wafers in Newly Diagnosed High-Grade Gliomas
Sign Up to like & getrecommendations! Published in 2018 at "Current Treatment Options in Neurology"
DOI: 10.1007/s11940-018-0489-2
Abstract: Purpose of reviewThe purpose of this study was to retrospectively evaluate the use of carmustine wafers (CWs) in the management of high-grade gliomas (HGGs). The data from our monoinstitutional series was compared with studies reported… read more here.
Keywords: grade gliomas; high grade; treatment; carmustine wafers ... See more keywords
In vitro Study of Serial Changes to Carmustine Wafers (Gliadel) with MR Imaging and Computed Tomography
Sign Up to like & getrecommendations! Published in 2018 at "Magnetic Resonance in Medical Sciences"
DOI: 10.2463/mrms.mp.2017-0035
Abstract: Purpose: Implantation of carmustine wafers (Gliadel) in vivo is accompanied by characteristic serial changes on MRI and CT, such as transient hyperintensity of the wafers on T1-weighted images (T1WIs) and considerable gas accumulation in surgical… read more here.
Keywords: wafer; serial changes; wafers gliadel; carmustine wafers ... See more keywords
Identification of a Prognostic Microenvironment-Related Gene Signature in Glioblastoma Patients Treated with Carmustine Wafers
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14143413
Abstract: Simple Summary Carmustine wafer (CW) implantation into the resection cavity of patients operated for glioblastoma (GBM) was approved as an adjuvant treatment before the Stupp Protocol. Although contrasting clinical results limited its use, our retrospective… read more here.
Keywords: carmustine wafers; microenvironment; patients treated; gene signature ... See more keywords